Products Description
Upadacitinib High selectivity for JAK1 target, oral small-molecule API. It inhibits the release of inflammatory cytokines with fast onset. High stereochemical purity and controllable impurities, suitable for generic drug R&D and API process development.
Products Specification
| Product name | ABT-494/Upadacitinib |
| CAS NO | 1310726-60-3 |
| ITEM NO | M163 |
| Appearance | White to off-white solid |
| Purity | ≥99% |
| λmax | 233 nm, 337 nm, 350 nm |
| Package | 1mg/25mg/200mg etc. |
| Delivery | 2-3days |
| Storage | -20°C |
| MSDS/COA/TDS | Connect us |
Products Application
Upadacitinib is a selective JAK1 inhibitor API, used for manufacturing oral medicines for autoimmune diseases including rheumatoid arthritis, atopic dermatitis and ulcerative colitis.
FAQ
Q: What is the target of Upadacitinib?
A: It is a selective JAK1 inhibitor, blocking inflammatory cytokine signaling pathway for autoimmune diseases.
Q: What diseases can the finished drug treat?
A: Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, ulcerative colitis and so on.
Q: Is this product for clinical use?
A: For R&D only, it is API raw material and cannot be directly used as finished medicine.
Q: What is the storage condition for Upadacitinib (ABT-494) powder?
A: Store at -20℃, sealed, protected from light and moisture.
Why Choose Zhengzhou Megma Chemical Co., Ltd.?
Quality at a Fair Price – High-quality chemicals delivered at reasonable prices.
Timely Delivery – Prompt order processing and shipment, with complete customs documentation tailored to each country's export policies.
Flexible & Secure Payment – Agile and reliable payment solutions you can trust.
Full Quality Commitment – Should any quality issue arise, we take full responsibility.
Market Insights – Price trend updates to keep you informed and ahead in sales.
Hot Tags: cas no:1310726-60-3 abt-494/upadacitinib, China cas no:1310726-60-3 abt-494/upadacitinib manufacturers, suppliers
